Patient-Reported Outcomes in Prostate Cancer: Prospective Changes Analysis for Prognosis Prediction


Prostate cancer is affecting a higher proportion of male population. Health Related Quality of Life assessment can guide the development of an interdisciplinary and patient-centered care intervention. This study is aimed to assess Health Related Quality of Life in prostate cancer patients. Relationships between socio-demographic, clinical characteristics and patient-reported outcomes have been considered. Consecutive outpatients with prostate cancer, admitted at the Urology Clinic of the Instituto Português de Oncologia do Porto, were studied (n = 300). Health Related Quality of Life was assessed as part of the routine practice. The European Organisation for Research and Treatment of Cancer general questionnaire, QLQ-C30, and its specific module for prostate cancer patients, QLQ-PR25, were used. Evolution along time (elapsed since diagnosis, and up to 5 years) was considered in order to search for a prognosis prediction in prostate cancer patients. This study confirms the feasibility of a systematic Health Related Quality of Life assessment. Global Health Related Quality of Life was found to be higher 6 months after diagnosis, decreasing then until the second year after diagnosis and improving thereafter. A peak with better scores was identified at the fifth year after diagnosis. Social and physical dimensions revealed a similar pattern. Clinical significance was found 6 months and 5 years after diagnosis. The prospective analysis of Health Related Quality of Life changes is able to explore the patients’ outcomes in order to find patterns and relationships for prognosis prediction along the disease course. Such approach might promote patient confidence and thus a better cancer experience.

Share and Cite:

Sequeira, T. , Ferreira, P. , Teixeira, J. , Peres, I. , Oliveira, J. and Silveira, A. (2015) Patient-Reported Outcomes in Prostate Cancer: Prospective Changes Analysis for Prognosis Prediction. Journal of Cancer Therapy, 6, 1238-1248. doi: 10.4236/jct.2015.615135.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Baade, P.D., Youlden, D.R., Cramb, S.M., Dunn, J. and Gardiner, R.A. (2013) Epidemiology of Prostate Cancer in the Asia-Pacific Region. Prostate International, 1, 47-58.
[2] Center, M.M, Jemal, A., Lortet-Tieulent, J., Ward, E., Ferlay, J., Brawley, O., et al. (2012) International Variation in Prostate Cancer Incidence and Mortality Rates. European Urology, 61, 1079-1092.
[3] Kessler, E.R. and Flaig, T.W. (2014) Geriatric Considerations in the Treatment of Advanced Prostate Cancer. F1000 Prime Reports, 6, 33.
[4] Droz, J.P., Balducci, L., Bolla, M., Emberton, M., Fitzpatrick, J.M., Joniau, S., Kattan, M.W., Monfardini, S., Moul, J.W., Naeim, A., van Poppel, H., Saad, F. and Sternberg, C.N. (2010) Management of Prostate Cancer in Older Men: Recommendations of a Working Group of the International Society of Geriatric Oncology. BJU International, 106, 462-469.
[5] Vander Walde, N.A., Fleming, M., Weiss, J. and Chera, B.S. (2013) Treatment of Older Patients with Head and Neck Cancer: A Review. Oncologist, 18, 568-578.
[6] Droz, J.P. and Chaladaj, A. (2008) Management of Metastatic Prostate Cancer: The Crucial Role of Geriatric Assessment. BJU International, 101, 23-29.
[7] Silveira, A., Goncalves, J., Sequeira, T., Ribeiro, C., Lopes, C., Monteiro, E. and Pimentel, F.L. (2011) Geriatric Oncology: Comparing Health Related Quality of Life in Head and Neck Cancer Patients. Head & Neck Oncology, 3, 3.
[8] Kordatou, Z., Kountourakis, P. and Papamichael, D. (2014) Treatment of Older Patients with Colorectal Cancer: A Perspective Review. Therapeutic Advances in Medical Oncology, 6, 128-140.
[9] Williams, G.R., Deal, A.M., Jolly, T.A., Alston, S.M., Gordon, B.B., Dixon, S.A., Olajide, O.A., Chris Taylor, W., Messino, M.J. and Muss, H.B. (2014) Feasibility of Geriatric Assessment in Community Oncology Clinics. Journal of Geriatric Oncology, 5, 245-251.
[10] Hamaker, M.E., Vos, A.G., Smorenburg, C.H., de Rooij, S.E. and van Munster, B.C. (2012) The Value of Geriatric Assessments in Predicting Treatment Tolerance and All-Cause Mortality in Older Patients with Cancer. Oncologist, 17, 1439-1449.
[11] Mohile, S., Dale, W. and Hurria, A. (2012) Geriatric Oncology Research to Improve Clinical Care. Nature Reviews Clinical Oncology, 9, 571-578.
[12] Green, L.E., Dinh, T.A., Hinds, D.A., Walser, B.L. and Allman, R. (2014) Economic Evaluation of Using a Genetic Test to Direct Breast Cancer Chemoprevention in White Women with a Previous Breast Biopsy. Applied Health Economics and Health Policy, 12, 203-217.
[13] Hofs, K., Bjordal, K., Diep, L.M. and Rustoen, T. (2014) The Relationships between Demographic and Clinical Characteristics and Quality of Life during and after Radiotherapy: In Women with Breast Cancer. Quality of Life Research, 23, 2769-2777.
[14] Song, L., Ji, Y. and Nielsen, M.E. (2014) Quality of Life and Health Status among Prostate Cancer Survivors and Noncancer Population Controls. Urology, 83, 658-663.
[15] Ferreira, P.L., Ferreira, L.N. and Pereira, L.N. (2013) Contribution for the Validation of the Portuguese Version of EQ-5D. Acta Médica Portuguesa, 26, 664-675.
[16] Silveira, A., Goncalves, J., Sequeira, T., Ribeiro, C., Lopes, C., Monteiro, E. and Pimentel, F.L. (2012) Head and Neck Cancer: Health Related Quality of Life Assessment Considering Clinical and Epidemiological Perspectives. Revista Brasileira de Epidemiologia, 15, 38-48.
[17] Cataudella, D., Morley, T.E., Nesin, A., Fernandez, C.V., Johnston, D.L., Sung, L. and Zelcer, S. (2014) Development of a Quality of Life Instrument for Children with Advanced Cancer: The Pediatric Advanced Care Quality of Life Scale (PAC-QoL). Pediatric Blood & Cancer, 61, 1840-1845.
[18] Wilcox, C.B., Gilbourd, D. and Louie-Johnsun, M. (2014) Anxiety and Health-Related Quality of Life (HRQL) in Patients Undergoing Active Surveillance of Prostate Cancer in an Australian Centre. BJU International, 113, 64-68.
[19] Wheelwright, S., Darlington, A.S., Fitzsimmons, D., Fayers, P., Arraras, J.I., Bonnetain, F., Brain, E., Bredart, A., Chie, W.C., Giesinger, J., Hammerlid, E., O’Connor, S.J., Oerlemans, S., Pallis, A., Reed, M., Singhal, N., Vassiliou, V., Young, T. and Johnson, C. (2013) International Validation of the EORTC QLQ-ELD14 Questionnaire for Assessment of Health-Related Quality of Life Elderly Patients with Cancer. British Journal of Cancer, 109, 852-858.
[20] Koczywas, M., Williams, A.C., Cristea, M., Reckamp, K., Grannis Jr., F.W., Tiep, B.L., Uman, G. and Ferrell, B. (2013) Longitudinal Changes in Function, Symptom Burden, and Quality of Life in Patients with Early-Stage Lung Cancer. Annals of Surgical Oncology, 20, 1788-1797.
[21] Bray, F., Lortet-Tieulent, J., Ferlay, J., Forman, D. and Auvinen, A. (2010) Prostate Cancer Incidence and Mortality Trends in 37 European Countries: An Overview. European Journal of Cancer, 46, 3040-3052.
[22] Neppl-Huber, C., Zappa, M., Coebergh, J.W., Rapiti, E., Rachtan, J., Holleczek, B., Rosso, S., Aareleid, T., Brenner, H. and Gondos, A., EUNICE Survival Working Group (2012) Changes in Incidence, Survival and Mortality of Prostate Cancer in Europe and the United States in the PSA Era: Additional Diagnoses and Avoided Deaths. Annals of Oncology, 23, 1325-1334.
[23] RORENO (2008).
[24] Projecoes de Incidência de cancro regiao Norte—2013, 2015 e 2020.
[25] Tobias-Machado, M., Carvalhal, G.F., Freitas Jr., C.H., Reis, R.B., Reis, L.O., Nogueira, L., Machado, R.D., Magnabosco, W., Vieira, R.A.C., Mauad, E.C., Carvalho, A.L. and Faria, E.F., Cooperative Brazilian Uro-Oncology Group (CBUG) (2013) Association between Literacy, Compliance with Prostate Cancer Screening, and Cancer Aggressiveness: Results from a Brazilian Screening Study. International Braz J Urol, 39, 328-334.
[26] Volka, R.J., Jibaja-Weissa, M.L., Hawleyb, S.T., Kneuperc, S., Spannc, S.J., Milesd, B.J. and Hymanc, D.J. (2008) Entertainment Education for Prostate Cancer Screening: A Randomized Trial among Primary Care Patients with Low Health Literacy. Patient Education and Counseling, 73, 482-489.
[27] Tyson, M., Andrews, P., Etzioni, D., Ferrigni, R., Humphreys, M., Swanson, S. and Castle, E. (2012) Marital Status and Prostate Cancer Outcomes. American Urological Association Annual Meeting, Atlanta, 19-23 May 2012, Abstract 171.
[28] Segal, R. (2014) Physical Functioning for Prostate Health. Canadian Urological Association Journal, 8, S162-S163.
[29] Storer, T.W., Miciek, R. and Travison, T.G. (2012) Muscle Function, Physical Performance and Body Composition Changes in Men with Prostate Cancer Undergoing Androgen Deprivation Therapy. Asian Journal of Andrology, 14, 204-221.
[30] Campbell, L.C., Keefe, F.J., McKee, D.C., Waters, S.J. and Moul, J.W. (2012) Masculinity Beliefs Predict Psychosocial Functioning in African American Prostate Cancer Survivors. American Journal of Men’s Health, 6, 400-408.
[31] Benedict, C., Traeger, L., Dahn, J.R., Antoni, M., Zhou, E.S., Bustillo, N. and Penedo, F.J. (2014) Sexual Bother in Men with Advanced Prostate Cancer Undergoing Androgen Deprivation Therapy. The Journal of Sexual Medicine, 11, 2571-2580.
[32] Kato, T., Komiya, A., Suzuki, H., Imamoto, T., Ueda, T. and Ichikawa, T. (2007) Effect of Androgen Deprivation Therapy on Quality of Life in Japanese Men with Prostate Cancer. International Journal of Urology, 14, 416-421.
[33] Torvinen, S., Farkkila, N., Sintonen, H., Saarto, T., Roine, R.P. and Taari, K. (2013) Health-Related Quality of Life in Prostate Cancer. Acta Oncologica, 52, 1094-1101.
[34] Ahmed, F., Burt, J. and Roland, M. (2014) Measuring Patient Experience: Concepts and Methods. The Patient— Patient-Centered Outcomes Research, 7, 235-241.
[35] Karnon, J., Partington, A., Horsfall, M. and Chew, D. (2015) Variation in Clinical Practice: A Priority Setting Approach to the Staged Funding of Quality Improvement. Applied Health Economics and Health Policy. (In Press)

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.